<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03973528</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201702097A3</org_study_id>
    <secondary_id>Chang Gung MH</secondary_id>
    <nct_id>NCT03973528</nct_id>
  </id_info>
  <brief_title>Primary Efficacy Evaluation of Traditional Chinese Medicine in Treating Older Infertile Women</brief_title>
  <official_title>A Preliminary Evaluation of the Efficacy of Traditional Chinese Medicine in Treating Elderly Women With Infertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a preliminary evaluation of the efficacy of traditional Chinese medicine in the
      treatment of elderly infertile women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research design: initial acceptance of 60 people, 30 in the no intervention group and 30 in
      the experimental group.

      The no intervention group no use Traditional Chinese medicine. The experimental group use
      Traditional Chinese medicine.

      Affect natural pregnancy and IVF success factors, the quality of ovarian function plays a
      very important role. Currently used to predict ovarian follicle inventory indicators,
      including: age, the total number of small sized ovarian follicles, the first three days of
      menstrual follicle-stimulating hormone, Anti-Mullerian hormone, inhibin-B.

      Research Analysis Chang Gung Memorial Hospital infertility patients using traditional Chinese
      medicine, more than 40-year-old infertility patients, the most commonly used compound is Zuo
      Gui Wan. Chinese medicine believes that elderly women with infertility ovulation poor, the
      main pathogenesis of kidney deficiency. The proportion of domestic infertility patients has
      increased year by year. Traditional Chinese medicine had become popular and acceptable, but
      the substantial evidence and treatment consensus of infertility are scanty.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 5, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum anti-Mullerian hormone (AMH) index</measure>
    <time_frame>three months</time_frame>
    <description>The efficacy of traditional Chinese medicine in the treatment of infertile women was evaluated by examining serum anti-Mullerian hormone (AMH) index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>total number of small ovarian follicles by the ultrasound examination (menstrual cramps 3-5 days).</measure>
    <time_frame>three months</time_frame>
    <description>The efficacy of traditional Chinese medicine in the treatment of infertile women was evaluated by the total number of small ovarian follicles by the ultrasound examination (menstrual cramps 3-5 days).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>traditional Chinese medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group use traditional Chinese medicine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non- traditional Chinese medicine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The no intervention group no use traditional Chinese medicine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>traditional Chinese medicine: tonifying kidney Wan</intervention_name>
    <description>traditional Chinese medicine : tonifying kidney Wan</description>
    <arm_group_label>traditional Chinese medicine</arm_group_label>
    <other_name>tonifying kidney Wan I: Zuo Gui Wan</other_name>
    <other_name>tonifying kidney Wan II :Guilu Erxian</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A. Women aged 35-45, married, without contraception, after 12 months of normal sexual
             life, did not take any contraceptive measures, and did not successfully conceive
             women.

        B. Blood tests for serum anti-Mullerian hormone ( AMH) less than 1.2, female hormones FSH,
        LH, E2 blood test is normal.

        C. Women who are not planning for IUI or IVF in the next three months. D. Menstrual cycle
        rules 21-35 days. E. Willing to sign a written consent form.

        Exclusion Criteria:

        A. Women with contraceptive. B. Vegetarians or have been taking Traditional Chinese
        medicine allergies. C. The following diseases have occurred in the past six months: cancer,
        high blood pressure, diabetes, heart disease, stroke, myocardial infarction,
        hyperthyroidism or hypothyroidism, chronic hepatitis, gastric ulcer, stomach bleeding,
        chronic constipation or diarrhea, major trauma and surgery, severe uterine and pelvic
        infections.

        D. Because of the need for disease, it is currently necessary to take western medicine for
        more than three months.

        E. Women with abnormal liver function (GOT, GPT greater than 2 times the upper limit of
        normal).

        F. Women with abnormal renal function (serum creatinine &gt; 1.5 mg/dl). G. Poor compliance
        with medication. H. In the past month, take a Traditional Chinese medicine to treat
        infertility. I. Take DHEA for the past month.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Evaluation of Traditional Chinese medicine treatment of infertile women older than 35 years of efficacy.</gender_description>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tsang-Tang Hsieh, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chang Gung MH IRB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming Chen Kao, MD</last_name>
    <phone>+886 3196200</phone>
    <phone_ext>2613</phone_ext>
    <email>small401@cgmh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shun-Li Kuo, MD</last_name>
    <phone>+886 3196200</phone>
    <phone_ext>2611</phone_ext>
    <email>barrington_kuo@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>33302</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Chen Kao, MD</last_name>
      <phone>+8863196200</phone>
      <phone_ext>2613</phone_ext>
      <email>small401@cgmh.org.tw</email>
    </contact>
    <contact_backup>
      <last_name>Shun Li Kuo, MD</last_name>
      <phone>+8863196200</phone>
      <phone_ext>2613</phone_ext>
      <email>barrington_kuo@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 2, 2019</study_first_submitted>
  <study_first_submitted_qc>June 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anti-Mullerian hormone (AMH)</keyword>
  <keyword>Traditional Chinese Medicine(TCM)</keyword>
  <keyword>Infertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

